Biblio Discovery — Demo Discovery Service

7 hasil untuk "Ze-Lin Zhan"

Menampilkan 1–7 · 0,88 detik · RSS

  1. Artikel Jurnal

    Comprehensive Analysis of Adverse Events Associated With SGLT2is: A Meta-Analysis Involving Nine Large Randomized Trials

    Mei Qiu; Li-Min Zhao; Ze-Lin Zhan

    Frontiers in Endocrinology, Vol. 12 · 2021 · Inggris · DOAJ Scopus

    Recently, Lin and colleagues assessed the safety of sodium-glucose cotransporter 2 inhibitors (SGLT2is) by a meta-analysis [1], in which the authors assessed 16 kinds of adverse events (AE) reported in the published articles based on 10 randomized controlled trials. We conducted a further…

  2. Artikel Jurnal

    Effects of SGLT2 inhibitors on cardiovascular death and all-cause death in patients with type 2 diabetes and chronic kidney disease: an updated meta-analysis including the SCORED trial

    Li-Min Zhao; Ze-Lin Zhan; Mei Qiu

    Therapeutic Advances in Endocrinology and Metabolism, Vol. 12 · 2021 · Inggris · DOAJ Scopus

    Background: The effects of sodium-glucose transporter 2 (SGLT2) inhibitors on cardiovascular death (CV death) and all-cause death (AC death) in patients with type 2 diabetes (T2D) and chronic kidney disease (CKD) are currently under intensive investigation. We intended to conduct an updated…

  3. Artikel Jurnal

    Meta-Analysis on the Safety and Cardiorenal Efficacy of SGLT2 Inhibitors in Patients Without T2DM

    Lu-Feng Li; Liang-Liang Ding; Ze-Lin Zhan dkk.

    Frontiers in Cardiovascular Medicine, Vol. 8 · 2021 · Inggris · DOAJ Scopus

    The cardiorenal benefits of sodium-glucose cotransporter 2 (SGLT2) inhibitors in patients with type 2 diabetes mellitus (T2DM) are established, whereas those in patients without T2DM are not established. We sought to assess the cardiorenal efficacy and safety of SGLT2 inhibitors in non-T2DM…